Skip to main content
Full access
Special Articles
Published Online: 27 February 2017

Psychiatric Presentations of C9orf72 Mutation: What Are the Diagnostic Implications for Clinicians?

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences

Abstract

The C9orf72 mutation was identified as the most frequent genetic cause of frontotemporal dementia (FTD). In light of multiple reports of predominant psychiatric presentations of FTD secondary to C9orf72 mutation, the American Neuropsychiatric Association Committee on Research reviewed all studies on psychiatric aspects of this mutation to identify clinically relevant features for diagnosis. The most common psychiatric presentation is psychosis (21%−56%), with delusions, and/or multimodal hallucinations. Other presentations include late-onset mania and depression with cognitive impairment or catatonia. However, the frequency of C9orf72 mutations is low in typical schizophrenia or bipolar disorders (<0.1%). The authors provide clinical guidance on diagnosis and genetic testing.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 195 - 205
PubMed: 28238272

History

Received: 9 September 2016
Revision received: 21 November 2016
Accepted: 22 November 2016
Published online: 27 February 2017
Published in print: Summer 2017

Keywords

  1. Frontotemporal Dementia
  2. C9orf72
  3. Genetics
  4. Psychosis
  5. Psychiatry

Authors

Affiliations

Simon Ducharme, M.D., M.Sc., F.R.C.P.(C) [email protected]
From the Departments of Psychiatry, Neurology & Neurosurgery, Montreal Neurological Institute and McGill University Health Centre, McGill University, Montreal, Quebec, Canada (S.D.); the Department of Psychiatry and Behavioral Sciences, Stanford University Hospital, Palo Alto, Calif. (S.B.); Massachusetts General Hospital, Harvard University, Boston (B.C.D.); and the Department of Behavioural and Clinical Neurosciences, Institute of Cambridge, University of Cambridge (V.V.).
Sepideh Bajestan, M.D., Ph.D.
From the Departments of Psychiatry, Neurology & Neurosurgery, Montreal Neurological Institute and McGill University Health Centre, McGill University, Montreal, Quebec, Canada (S.D.); the Department of Psychiatry and Behavioral Sciences, Stanford University Hospital, Palo Alto, Calif. (S.B.); Massachusetts General Hospital, Harvard University, Boston (B.C.D.); and the Department of Behavioural and Clinical Neurosciences, Institute of Cambridge, University of Cambridge (V.V.).
Bradford C. Dickerson, M.D.
From the Departments of Psychiatry, Neurology & Neurosurgery, Montreal Neurological Institute and McGill University Health Centre, McGill University, Montreal, Quebec, Canada (S.D.); the Department of Psychiatry and Behavioral Sciences, Stanford University Hospital, Palo Alto, Calif. (S.B.); Massachusetts General Hospital, Harvard University, Boston (B.C.D.); and the Department of Behavioural and Clinical Neurosciences, Institute of Cambridge, University of Cambridge (V.V.).
Valerie Voon, M.D., Ph.D.
From the Departments of Psychiatry, Neurology & Neurosurgery, Montreal Neurological Institute and McGill University Health Centre, McGill University, Montreal, Quebec, Canada (S.D.); the Department of Psychiatry and Behavioral Sciences, Stanford University Hospital, Palo Alto, Calif. (S.B.); Massachusetts General Hospital, Harvard University, Boston (B.C.D.); and the Department of Behavioural and Clinical Neurosciences, Institute of Cambridge, University of Cambridge (V.V.).

Notes

Send correspondence to Dr. Ducharme; e-mail: [email protected]
Previously presented at the 27th Annual Meeting of the American Neuropsychiatric Association, March 3, 2016, San Diego.

Competing Interests

Dr. Ducharme receives salary funding from the Fonds de Recherche du Québec-Santé. All other authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share